MPXX Information

Our company is the proprietor of the patented MPXX™ technology. Our mission consists in protecting the health and improving the lives of people by providing unique, scientifically proven solutions in the area of safety and prevention. Our technology cuts allergenic proteins, allergens & chemical residues from Natural Rubber Latex & synthetic rubber products to unquantifiable & undetectable levels. Hence, it enables maximum protection & ultimate prevention by eliminating the risk of type I and IV allergies. Our passion & expertise date back to 1995, when the founder of the Dutch R & D company BUDEV, strongly aware of the importance of the growing latex allergy & occupational safety issues, initiated the research & development of MPXX™. In co-operation with scientific partner-organizations such as the Erasmus University Medical Centre in Rotterdam & the Malaysian Rubber Board, Budev BV developed and patented different technologies, including MPXX™. Budev’s objective was to implement MPXX™ technology worldwide with selected dynamic partners who had an excellent track-record in quality & efficiency within the medical and industrial sector & opted to apply the MPXX™ technology first on medical gloves. In 2015 we changed our name into MPXX, matching it with our technology which represents the core of our business and is the key to our success. To maximize the reach & the benefits of the revolutionary MPXX™ technology, we are executing R&D for its application, feasibility & implementation on other Natural Rubber Latex or synthetic rubber products. In our company we are obsessed with quality: products treated with the MPXX™ technology exceed all international standards and are constantly subjected to different types of tests executed by international accredited laboratories. With superior products, corporate responsibility and strong values we are proud to offer unique solutions for health, safety and well-being proving that we care for you.